معرفی
Liesbeth Lewi serves as an Associate Professor at KU Leuven's Faculty of Medicine within the Department of Development and Regeneration. She holds dual affiliations with the Woman and Child unit at UZ Leuven (Herestraat 49, box 7003) and Leuven.IRD - KU Leuven Institute for Rare Diseases. Her institutional roles include membership on the Council of the Faculty of Medicine and the Council of the Department of Development and Regeneration as senior academic staff.
Her research focuses on high-risk twin pregnancies, particularly selective fetal growth restriction in monochorionic twins, placental pathology, and hemolytic disease management. Current leadership includes the Twin Growth Project (2022-2027), Outcomes of Monochorial Diamniotic Twin Pregnancies (2025-2029), and CONTRAST initiative (2023-2024). Her methodology integrates international multicenter cohort studies, ultrasound innovation, and systematic reviews of perinatal interventions.
Analysis of her 2025 publications reveals dominant themes in obstetric ultrasound standardization, twin placental pathophysiology, and evidence-based management of fetal growth disorders. Key trends include international guideline development (ISUOG), Doppler flow analysis for predicting adverse outcomes, and novel echocardiography techniques for twin surveillance.
Her teaching portfolio encompasses advanced problem-solving courses in gynecology and obstetrics (E0J61A-E0J71A), evidence-based medicine (E0AA5A), and clinical research methodology (E0C63B) across KU Leuven's medical curriculum.
Laboratory and clinical operations center on the Woman and Child unit's fetal medicine research infrastructure, with active collaboration in Leuven.IRD's rare disease networks. Current projects investigate placental vascular anastomoses, umbilical cord insertion pathologies, and postpartum hemorrhage interventions through interventional radiology.
